Hydroxyurea may enhance effectiveness of anti-HIV regimens presently in use.
Murphy
M J
MJ
D019380:Anti-HIV Agents / Q000494:pharmacology / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D006918:Hydroxyurea / Q000494:pharmacology* / Q000627:therapeutic use; D012264:Ribonucleotide Reductases / Q000037:antagonists & inhibitors
D019380:Anti-HIV Agents; D000970:Antineoplastic Agents; D017320:HIV Protease Inhibitors; D012264:Ribonucleotide Reductases; D006918:Hydroxyurea